Biology Reference
In-Depth Information
McGrath ME (1999) The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct
28:181-204
McGrath ME, Klaus JL, Barnes MG, Bromme D (1997) Crystal structure of human cathepsin K
complexed with a potent inhibitor. Nat Struct Biol 4:105-109
McGrath ME, Palmer JT, Bromme D, Somoza JR (1998) Crystal structure of human cathepsin S.
Protein Sci 7:1294-1302
McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM (2000) Inflam-
mation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science
289:1202-1206
Mellor GW, Thomas EW, Topham CM, Brocklehurst K (1993) Ionization characteristics of the
Cys-25/His-159 interactive system and of the modulatory group of papain: resolution of
ambiguity by electronic perturbation of the quasi-2-mercaptopyridine leaving group in a new
pyrimidyl disulphide reactivity probe. Biochem J 290(Pt 1):289-296
Miller EJ, Harris ED Jr, Chung E, Finch JE Jr, McCroskery PA, Butler WT (1976) Cleavage of
Type II and III collagens with mammalian collagenase: site of cleavage and primary structure
at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemis-
try 15:787-792
Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat
Rev Cancer 6:764-775
Molgaard A, Arnau J, Lauritzen C, Larsen S, Petersen G, Pedersen J (2007) The crystal structure of
human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.
Biochem J 401:645-650
Morrison CJ, Butler GS, Rodriguez D, Overall CM (2009) Matrix metalloproteinase proteomics:
substrates, targets, and therapy. Curr Opin Cell Biol 21:645-653
Mort JS, Magny MC, Lee ER (1998) Cathepsin B: an alternative protease for the generation of an
aggrecan 'metalloproteinase' cleavage neoepitope. Biochem J 335:491-494
Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, Bayne EK,
Flanagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbauer M, Visco DM (1998)
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage
destruction. Arthritis Rheum 41:110-121
Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N,
Bode W (1991) The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the
structural basis for its specificity. EMBO J 10:2321-2330
Naghavi M, John R, Naguib S, Siadaty MS, Grasu R, Kurian KC, van Winkle WB, Soller B,
Litovsky S, Madjid M, Willerson JT, Casscells W (2002) pH Heterogeneity of human and
rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atheroscle-
rosis 164:27-35
Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD,
Eastman SE, Howard ED, Clarke SR, Rosloniec EF, Elliott EA, Rudensky AY (1999) Impaired
invariant chain degradation and antigen presentation and diminished collagen-induced arthritis
in cathepsin S null mice. Immunity 10:207-217
Newby AC (2006) Do metalloproteinases destabilize vulnerable atherosclerotic plaques? Curr
Opin Lipidol 17:556-561
Nguyen Q, Mort JS, Roughley PJ (1990) Cartilage proteoglycan aggregate is degraded more
extensively by cathepsin L than by cathepsin B. Biochem J 266:569-573
Nosaka AY, Kanaori K, Teno N, Togame H, Inaoka T, Takai M, Kokubo T (1999) Conformational
studies on the specific cleavage site of Type I collagen (alpha-1) fragment (157-192) by
cathepsins K and L by proton NMR spectroscopy. Bioorg Med Chem 7:375-379
Overall CM, Blobel CP (2007) In search of partners: linking extracellular proteases to substrates.
Nat Rev Mol Cell Biol 8:245-257
Page AE, Hayman AR, Andersson LMB, Chambers TJ, Warburton MJ (1993) Degradation of
bone matrix proteins by osteoclast cathepsins. Int J Biochem 25:545-550
